Jiang Zhong Pharmaceutical Co.,Ltd (SHA:600750)

SHA:600750 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	4,314	4,404	4,527	3,846	2,856	2,435
Other Revenue	31.51	31.51	26.23	39.58	17.88	6.9
Revenue	4,346	4,435	4,553	3,885	2,874	2,441
Revenue Growth (YoY)	-3.04%	-2.59%	17.19%	35.19%	17.72%	-0.33%
Cost of Revenue	1,590	1,634	1,648	1,384	1,026	847.82
Gross Profit	2,756	2,801	2,906	2,501	1,848	1,594
Selling, General & Admin	1,684	1,724	1,862	1,713	1,196	962.24
Research & Development	127.45	130.43	141.42	99.97	87.82	55.55
Other Operating Expenses	12.32	41.58	55.35	59.31	52.48	45.71
Operating Expenses	1,831	1,904	2,058	1,874	1,336	1,065
Operating Income	924.29	897.39	847.35	626.7	511.29	528.48
Interest Expense	-1.71	-1.71	-6.98	-4.38	-3.46	-1.93
Interest & Investment Income	77.59	77.48	68.79	37	26.3	15.27
Other Non Operating Income (Expenses)	5.73	22.09	-2.29	-12.33	-8.77	-0.06
EBT Excluding Unusual Items	1,006	995.25	906.87	646.99	525.36	541.75
Gain (Loss) on Sale of Investments	-12.03	-11.46	-40.05	57.1	51.25	-15.85
Gain (Loss) on Sale of Assets	1.79	1.84	1.22	-0.13	0.9	-0.21
Asset Writedown	7.8	-1.05	-2.04	-	-	-
Other Unusual Items	41.03	41.03	50.12	49.32	45.63	53.7
Pretax Income	1,045	1,026	916.12	753.28	623.14	579.4
Income Tax Expense	166.39	165.11	129.11	106.89	92.19	89.07
Earnings From Continuing Operations	878.27	860.51	787.01	646.39	530.95	490.32
Net Income to Company	878.27	860.51	787.01	646.39	530.95	490.32
Minority Interest in Earnings	-74.18	-72.31	-68.34	-48.15	-25.26	-16.58
Net Income	804.09	788.19	718.67	598.24	505.69	473.74
Net Income to Common	804.09	788.19	718.67	598.24	505.69	473.74
Net Income Growth	7.91%	9.67%	20.13%	18.30%	6.74%	2.19%
Shares Outstanding (Basic)	632	631	719	630	632	632
Shares Outstanding (Diluted)	632	631	719	630	632	632
Shares Change (YoY)	-12.11%	-12.26%	14.12%	-0.38%	0.07%	0.83%
EPS (Basic)	1.27	1.25	1.00	0.95	0.80	0.75
EPS (Diluted)	1.27	1.25	1.00	0.95	0.80	0.75
EPS Growth	22.78%	25.00%	5.26%	18.75%	6.67%	1.35%
Free Cash Flow	602.79	495.49	828.31	676.02	728.55	569.97
Free Cash Flow Per Share	0.95	0.79	1.15	1.07	1.15	0.90
Dividend Per Share	1.200	1.200	1.300	1.150	0.650	0.270
Dividend Growth	-7.69%	-7.69%	13.04%	76.92%	140.74%	8.00%
Gross Margin	63.41%	63.16%	63.81%	64.37%	64.29%	65.27%
Operating Margin	21.27%	20.23%	18.61%	16.13%	17.79%	21.65%
Profit Margin	18.50%	17.77%	15.78%	15.40%	17.59%	19.40%
Free Cash Flow Margin	13.87%	11.17%	18.19%	17.40%	25.35%	23.34%
EBITDA	1,060	1,031	971.28	746.78	626.2	641.24
EBITDA Margin	24.39%	23.24%	21.33%	19.22%	21.79%	26.27%
D&A For EBITDA	135.56	133.24	123.94	120.08	114.91	112.77
EBIT	924.29	897.39	847.35	626.7	511.29	528.48
EBIT Margin	21.27%	20.23%	18.61%	16.13%	17.79%	21.65%
Effective Tax Rate	15.93%	16.10%	14.09%	14.19%	14.79%	15.37%
Revenue as Reported	4,435	4,435	4,553	3,885	2,874	2,441
Advertising Expenses	-	364.67	404.92	318.77	321.22	255.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.